Carrimycin

DB16476InvestigationalSmall molecule

Carrimycin: Overview.

Mechanism: Carrimycin is used in clinical trials to determine anti-SARS-CoV-2 activity. Its actions involve inhibiting protein synthesis through binding to the ribosome of bacteria.
Curator reviewed
Also known as: 4''-Isovalerylspiramycin

Resolves to

Compound

Targets

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Carrimycin, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.